D. E. Shaw & Co., Inc. Lantheus Holdings, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 2,291 shares of LNTH stock, worth $204,563. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,291

Holding current value

$204,563

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$77.7 - $123.62 $2.27 Million - $3.61 Million	-29,183 Reduced 92.72%	2,291 $251,000
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $81,005 - $114,276	-1,376 Reduced 4.19%	31,474 $2.53 Million
Q1 2024 May 15, 2024	SELL	$51.07 - $68.26 $541,954 - $724,375	-10,612 Reduced 24.42%	32,850 $2.04 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $7.11 Million - $9.96 Million	-127,894 Reduced 74.64%	43,462 $2.69 Million
Q3 2023 Nov 14, 2023	SELL	$60.27 - $90.75 $23.3 Million - $35.1 Million	-386,997 Reduced 69.31%	171,356 $11.9 Million
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $14.8 Million - $17.9 Million	179,242 Added 47.28%	558,353 $46.9 Million
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $601,537 - $1.04 Million	12,595 Added 3.44%	379,111 $31.3 Million
Q4 2022 Feb 14, 2023	BUY	$48.76 - $77.67 $17.9 Million - $28.5 Million	366,516 New	366,516 $18.7 Million
Q2 2022 Aug 15, 2022	SELL	$55.54 - $72.65 $8.45 Million - $11.1 Million	-152,215 Reduced 40.47%	223,862 $14.8 Million
Q1 2022 May 16, 2022	BUY	$24.28 - $56.64 $9.13 Million - $21.3 Million	376,077 New	376,077 $20.8 Million
Q3 2018 Nov 14, 2018	SELL	$13.1 - $16.35 $244,550 - $305,221	-18,668 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.65 - $18.7 $254,818 - $349,091	18,668 New	18,668 $272,000

Others Institutions Holding LNTH

# of Institutions

540

Shares Held

68M

Call Options Held

679K

Put Options Held

423K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.14B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account